Why and how the old neuroleptic thioridazine cures the XDR-TB patient

Leonard Amaral, J. Molnár

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This mini-review provides the entire experimental history of the development of the old neuroleptic thioridazine (TZ) for therapy of antibiotic resistant pulmonary tuberculosis infections. TZ is effective when used in combination with antibiotics to which the initial Mycobacterium tuberculosis was resistant. Under proper cardiac evaluation procedures, the use of TZ is safe and does not produce known cardiopathy such as prolongation of QT interval. Because TZ is cheap, it should be considered for therapy of XDR and TDR-Mtb patients in economically disadvantaged countries.

Original languageEnglish
Pages (from-to)1021-1031
Number of pages11
JournalPharmaceuticals
Volume5
Issue number9
DOIs
Publication statusPublished - Jul 17 2012

Fingerprint

Extensively Drug-Resistant Tuberculosis
Thioridazine
Antipsychotic Agents
Anti-Bacterial Agents
Vulnerable Populations
Pulmonary Tuberculosis
Mycobacterium tuberculosis
History
Therapeutics
Infection

Keywords

  • Cures the human of an XDR-TB infection
  • Cures the mouse of MDR-Mtb infections
  • Enhances killing of intracellular Mtb
  • Ex vivo activity
  • In vitro activity
  • Inhibitor of efflux pumps
  • Mechanisms of action
  • Pulmonary tuberculosis
  • TDR-TB
  • Thioridazine
  • XDR-TB

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Why and how the old neuroleptic thioridazine cures the XDR-TB patient. / Amaral, Leonard; Molnár, J.

In: Pharmaceuticals, Vol. 5, No. 9, 17.07.2012, p. 1021-1031.

Research output: Contribution to journalArticle

@article{261053ae65fd4f3ab82b039dbbee69c1,
title = "Why and how the old neuroleptic thioridazine cures the XDR-TB patient",
abstract = "This mini-review provides the entire experimental history of the development of the old neuroleptic thioridazine (TZ) for therapy of antibiotic resistant pulmonary tuberculosis infections. TZ is effective when used in combination with antibiotics to which the initial Mycobacterium tuberculosis was resistant. Under proper cardiac evaluation procedures, the use of TZ is safe and does not produce known cardiopathy such as prolongation of QT interval. Because TZ is cheap, it should be considered for therapy of XDR and TDR-Mtb patients in economically disadvantaged countries.",
keywords = "Cures the human of an XDR-TB infection, Cures the mouse of MDR-Mtb infections, Enhances killing of intracellular Mtb, Ex vivo activity, In vitro activity, Inhibitor of efflux pumps, Mechanisms of action, Pulmonary tuberculosis, TDR-TB, Thioridazine, XDR-TB",
author = "Leonard Amaral and J. Moln{\'a}r",
year = "2012",
month = "7",
day = "17",
doi = "10.3390/ph5091021",
language = "English",
volume = "5",
pages = "1021--1031",
journal = "Pharmaceuticals",
issn = "1424-8247",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "9",

}

TY - JOUR

T1 - Why and how the old neuroleptic thioridazine cures the XDR-TB patient

AU - Amaral, Leonard

AU - Molnár, J.

PY - 2012/7/17

Y1 - 2012/7/17

N2 - This mini-review provides the entire experimental history of the development of the old neuroleptic thioridazine (TZ) for therapy of antibiotic resistant pulmonary tuberculosis infections. TZ is effective when used in combination with antibiotics to which the initial Mycobacterium tuberculosis was resistant. Under proper cardiac evaluation procedures, the use of TZ is safe and does not produce known cardiopathy such as prolongation of QT interval. Because TZ is cheap, it should be considered for therapy of XDR and TDR-Mtb patients in economically disadvantaged countries.

AB - This mini-review provides the entire experimental history of the development of the old neuroleptic thioridazine (TZ) for therapy of antibiotic resistant pulmonary tuberculosis infections. TZ is effective when used in combination with antibiotics to which the initial Mycobacterium tuberculosis was resistant. Under proper cardiac evaluation procedures, the use of TZ is safe and does not produce known cardiopathy such as prolongation of QT interval. Because TZ is cheap, it should be considered for therapy of XDR and TDR-Mtb patients in economically disadvantaged countries.

KW - Cures the human of an XDR-TB infection

KW - Cures the mouse of MDR-Mtb infections

KW - Enhances killing of intracellular Mtb

KW - Ex vivo activity

KW - In vitro activity

KW - Inhibitor of efflux pumps

KW - Mechanisms of action

KW - Pulmonary tuberculosis

KW - TDR-TB

KW - Thioridazine

KW - XDR-TB

UR - http://www.scopus.com/inward/record.url?scp=84866532211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866532211&partnerID=8YFLogxK

U2 - 10.3390/ph5091021

DO - 10.3390/ph5091021

M3 - Article

VL - 5

SP - 1021

EP - 1031

JO - Pharmaceuticals

JF - Pharmaceuticals

SN - 1424-8247

IS - 9

ER -